ABRN Pharma

Founded: 2012 • Age: 14 yrs
Pharmaceutical formulations, APIs, nutraceuticals, and anti-cancer drugs manufacturing, distribution, and exporting.
Annual revenue $422,490 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About ABRN Pharma

Data last updated:

ABRN Pharma is a company founded in 2012. ABRN Pharma offers products and services including Tablets and Anti-Cancer Drugs.

Operational Areas
Healthcare β†’ Healthcare Products & Supplies → Unlock Sub-Sector → Unlock Segment
Healthcare β†’ Pharmaceuticals & Therapeutics → Unlock Sub-Sector → Unlock Segment
Key Metrics
  • Annual Revenue
    $422.49 K (USD)
    30.02
    as on Mar 31, 2023
  • Net Profit
    $12.04 K (USD)
    -19.22
    as on Mar 31, 2023
  • EBITDA
    $16.28 K (USD)
    -14.33
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ABRN Pharma

ABRN Pharma offers a comprehensive portfolio of products and services, including Tablets and Anti-Cancer Drugs.

Product name locked
Category locked
Primary

Tablets are manufactured and distributed for various health applications, utilizing premium grade ingredients

Product name locked
Category locked
Locked

Anti-cancer drugs like Dactinomycin and Methotrexate are provided for cancer treatment, ensuring effectiveness and purity

Funding Insights of ABRN Pharma

Premium access

Detailed funding history for ABRN Pharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ABRN Pharma

Investments
Premium access

Investment portfolio details for ABRN Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ABRN Pharma

Premium access

Detailed financials for ABRN Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Abrn Pharma Comparisons

ABRN Pharma Primary company
Description
Pharmaceutical formulations, APIs, nutraceuticals, and anti-...
Location
-
Founded Year
2012
Annual Revenue
$422.49 K (USD)
Net Profit
$12.04 K (USD)
EBITDA
$16.28 K (USD)
Employees
Not available
Premium access

Peer comparison for ABRN Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ABRN Pharma

Premium access

Detailed competitors of ABRN Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Abrn Pharma

Premium access

Complete news archive for ABRN Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ABRN Pharma

ABRN Pharma was founded in 2012.

Annual revenue of ABRN Pharma is $422.49K as on Mar 31, 2023.

ABRN Pharma Private Limited was established in 2012 and is recognized for its engagement in exporting, distributing, supplying, and marketing a diverse range of pharmaceutical formulations, APIs, nutraceuticals, and anti-cancer drugs. Products such as Dactinomycin, Cytarabine, and Methotrexate are formulated using premium grade ingredients sourced from reliable vendors, ensuring features like high effectiveness, purity, and longer shelf life. The company operates from Navi Mumbai, India, and its cancer drugs are noted for treating various cancers, with exports to multiple countries worldwide. Operations are led by experienced professionals committed to quality standards.

ABRN Pharma offers Tablets and Anti-Cancer Drugs.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available